Calhoun DA - Search Results

1

Recent advances in neonatal pharmacotherapy.

Calhoun DA, Murthy SN, Bryant BG, Luedtke SA, Bhatt-Mehta V. Calhoun DA, et al. Ann Pharmacother. 2006 Apr;40(4):710-9. doi: 10.1345/aph.1G212. Epub 2006 Mar 28. Ann Pharmacother. 2006. PMID: 16569801 Review.

2

Tolerance of simulated amniotic fluid in premature neonates.

Sullivan SE, Calhoun DA, Maheshwari A, Ashmeade TL, Auerbach DA, Hudak ML, Beltz SE, Christensen RD. Sullivan SE, et al. Among authors: calhoun da. Ann Pharmacother. 2002 Oct;36(10):1518-24. doi: 10.1345/aph.1A439. Ann Pharmacother. 2002. PMID: 12243599 Clinical Trial.

3

Pharmacologic management of neonatal abstinence syndrome in a community hospital.

Napolitano A, Theophilopoulos D, Seng SK, Calhoun DA. Napolitano A, et al. Among authors: calhoun da. Clin Obstet Gynecol. 2013 Mar;56(1):193-201. doi: 10.1097/GRF.0b013e31827adf91. Clin Obstet Gynecol. 2013. PMID: 23314713 Review.

4

Hematopoietic growth factors in neonatal medicine: the use of enterally administered hematopoietic growth factors in the neonatal intensive care unit.

Calhoun DA, Christensen RD. Calhoun DA, et al. Clin Perinatol. 2004 Mar;31(1):169-82. doi: 10.1016/j.clp.2004.03.001. Clin Perinatol. 2004. PMID: 15183665 Review.

5

Resistance to recombinant human granulocyte colony-stimulating factor in neonatal alloimmune neutropenia associated with anti-human neutrophil antigen-2a (NB1) antibodies.

Maheshwari A, Christensen RD, Calhoun DA. Maheshwari A, et al. Among authors: calhoun da. Pediatrics. 2002 Apr;109(4):e64. doi: 10.1542/peds.109.4.e64. Pediatrics. 2002. PMID: 11927737

6

Persistent perianal abscess in early infancy as a presentation of autoimmune neutropenia.

Lejkowski M, Maheshwari A, Calhoun DA, Christensen RD, Skoda-Smith S, Dabrow S. Lejkowski M, et al. Among authors: calhoun da. J Perinatol. 2003 Jul-Aug;23(5):428-30. doi: 10.1038/sj.jp.7210952. J Perinatol. 2003. PMID: 12847542

7

Bioavailability of granulocyte colony-stimulating factor administered enterally to suckling mice.

Gersting JA, Kotto-Kome CA, Du Y, Christensen RD, Calhoun DA. Gersting JA, et al. Among authors: calhoun da. Pharmacol Res. 2003 Dec;48(6):643-7. doi: 10.1016/s1043-6618(03)00249-4. Pharmacol Res. 2003. PMID: 14527831

8

Stability of filgrastim and epoetin alfa in a system designed for enteral administration in neonates.

Calhoun DA, Juul SE, McBryde EV, Veerman MW, Christensen RD. Calhoun DA, et al. Ann Pharmacother. 2000 Nov;34(11):1257-61. doi: 10.1345/aph.10105. Ann Pharmacother. 2000. PMID: 11098337

9

IL-8/CXC ligand 8 survives neonatal gastric digestion as a result of intrinsic aspartyl proteinase resistance.

Maheshwari A, Lu W, Guida WC, Christensen RD, Calhoun DA. Maheshwari A, et al. Among authors: calhoun da. Pediatr Res. 2005 Mar;57(3):438-44. doi: 10.1203/01.PDR.0000151317.08180.7E. Epub 2004 Dec 7. Pediatr Res. 2005. PMID: 15585673

10

Effect of administering recombinant erythropoietin to women with postpartum anemia: a meta-analysis.

Kotto-Kome AC, Calhoun DA, Montenegro R, Sosa R, Maldonado L, Christensen RD. Kotto-Kome AC, et al. Among authors: calhoun da. J Perinatol. 2004 Jan;24(1):11-5. doi: 10.1038/sj.jp.7211017. J Perinatol. 2004. PMID: 14726931

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

308 results

Search Page